Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Supply of Potassium Iodide Tablets (130mg)

Active

Federal

Response Deadline09/29/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of 130mg Potassium Iodide tablets for prime contractors. The requirement specifies the delivery of 24 packages, each containing 14 tablets in foil-sealed units, to be performed at Tyndall Air Force Base. All products must adhere to a non-extendable shelf life of 120 months as per NSN 6505-01-496-4916 and be maintained at temperatures between 68 and 77 degrees Fahrenheit. To qualify, providers must hold the necessary pharmaceutical manufacturing licenses and maintain full FDA compliance. The opportunity was posted on September 23, 2026, with a response deadline of September 29, 2026. This procurement falls under NAICS code 325412 for pharmaceutical preparation.

General Info

Supply 24 packages of Potassium Iodide tablets to Tyndall Air Force Base.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

TYNDALL AFB, FL, 32403-5604, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-5204.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

POTASSIUM IODIDE TABLE

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedSep 23

subcontract

Response DeadlineSep 29

Submission deadline

Response Deadline

09/29/2026, 05:00:00 PM UTCin 6 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supplies 130mg Potassium Iodide (KI) tablets for prime contractors on DLA Troop Support Medical Supply Chain projects. Provides tablets in 14-unit dose, foil-sealed packages maintained at 20-25°C (68-77°F). Ensures product meets a non-extendable shelf life of 120 months per NSN 6505-01-496-4916. Requires pharmaceutical manufacturing licenses and FDA compliance. Delivers 24 packages of 14 tablets each.

Similar Contracts

Same NAICS industry code

Apraclonidine Hydrochloride Ophthalmic Solution ManufacturingThis subcontract involves the pharmaceutical manufacturing of 1% Apraclonidine Hydrochloride Ophthalmic Solution to support prime contractors delivering medical supplies to DLA Troop Support. The selected provider is responsible for the chemical synthesis and formulation of the solution to pharmaceutical grade specifications, requiring the use of API Apraclonidine Hydrochloride and specialized manufacturing facilities. To ensure quality and safety, the manufacturer must maintain active FDA registration and adhere to current good Manufacturing Practice compliance. The final deliverable is the finished ophthalmic solution, with performance taking place in San Antonio, Texas, under the oversight of the Department of Defense Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

Supply of Moxifloxacin Hydrochloride Tablets (400 MG)This subcontract involves the supply of pharmaceutical-grade Moxifloxacin Hydrochloride Tablets, 400 MG, for prime contractors supporting MEDICAL SUPPLY CHAIN PHARM FSA projects under the Department of Defense. The provider is responsible for manufacturing or sourcing the medication ensuring exact dosage and utilizing GMP-compliant facilities with climate-controlled storage to prevent humidity damage. All products must adhere to FDA and GMP standards, as well as RP001 DLA Packaging Requirements, with delivery specified in bottles of 30 units each. The opportunity is categorized under NAICS code 325412 and is associated with a place of performance in FPO 09591. The solicitation was posted on September 23, 2026, with a response deadline of September 29, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

Supply of Dextrose Oral Gel (15g Packages)This subcontract involves the supply of pharmaceutical-grade Dextrose Oral Gel in 15g packages for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The provider is responsible for manufacturing or sourcing the product to ensure a total shelf life of 18 months, with a strict requirement that no more than 15 months pass between the date of manufacture and delivery. All deliverables must strictly adhere to DLA Packaging Requirements RP001 and General Technical and Quality Requirements RA001. The contract specifies delivery to designated DLA locations, with the place of performance centered in Groton, Massachusetts. This procurement falls under NAICS code 325412 and is managed through the DLA Troop Support Medical Supply Chain.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

DIBUCAINE OINTMENT

Solicitation # SPE2DP-26-T-5207

This contract is for the procurement of Dibucaine Ointment USP, containing 1 percent active ingredient, supplied in one ounce or 28 gram packages with a collapsible tube and rectal applicator. The product is regulated by the FDA and must be stored between 15 and 30 degrees Celsius. It carries a non-extendable shelf life of 36 months and must be marked according to Medical Marking Standard No. 1. The order consists of three packages under contract SPE2DP-26-T-5207, with a delivery requirement of 20 days after order. Shipping is FOB destination to the USNS Henson. Packaging must comply with DLA requirements and MIL-STD-129, with specific guidelines for hazardous or commercial packaging based on FED-STD-313 and ASTM D3951.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

TOLNAFTATE POWDER

Solicitation # SPE2DP-26-T-5209

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

DETERGENT, SURGICAL

Solicitation # SPE2DP-26-T-5210

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

MOXIFLOXACIN HYDROC

Solicitation # SPE2DP-26-T-5203

Solicitation SPE2DP-26-T-5203 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Moxifloxacin Hydrochloride 400 mg tablets. The items are supplied in bottles containing 30 tablets each, with the bottle serving as the unit of issue. The procurement includes multiple line items with quantities ranging from 3 to 14 bottles. The drug is FDA-regulated and must be stored at controlled room temperature, avoiding high humidity. It carries a non-extendable shelf life of 36 months and must be marked according to Medical Marking Standard No. 1. Delivery is required within 20 days of order, with FOB Destination terms. Shipments are destined for various locations, including the USS Lewis B Puller and USS Sampson, as well as facilities in North Carolina and Kentucky. Packaging must comply with DLA Master List of Technical and Quality Requirements, ASTM D3951 for non-hazardous materials, and RP001 for palletization. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system. The solicitation is categorized under NAICS 325412 and incorporates various FAR and DFARS clauses regarding cybersecurity, domestic preferences, and the safeguarding of covered defense information.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

PHARM MANUF/DISTR DIV - FSA

Solicitation # SPE2D2-26-R-0013

The Defense Logistics Agency is preparing to issue a national requirements contract for Methylphenidate ER Tablets in 18MG, 27MG, 36MG, and 54MG strengths, packaged in 100-count bottles. This procurement will be conducted as an unrestricted, fully competitive acquisition under FAR Part 12 as a commercial item, using a firm-fixed-price, requirements-type contract structure with a one-year base period and four one-year option periods. The resulting contract will serve as the national supply source for Methylphenidate ER Tablets, supplying the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through the DLA and VA prime vendor programs. Annual usage estimates will be specified in the solicitation’s schedule, and all eligible sources may submit proposals. The contract is designed to ensure consistent, nationwide availability of this critical medication. The solicitation, numbered SPE2D226R0013, is currently in the pre-solicitation phase with a projected release date in September 2026, though the agency retains the right to issue it earlier or later. The contract will be posted on both the DLA Bid Board System and SAM.gov, and interested parties are encouraged to monitor these sites and set up automated notifications for updates. All correspondence should be directed to Jeremy Brown at jeremy.brown@dla.mil or (445) 737-5419, with Jason Wray available as a secondary point of contact. The acquisition is managed by DLA Troop Support, headquartered in Philadelphia, Pennsylvania, and is classified under NAICS code 325412 for pharmaceutical preparation manufacturing.

MEDICAL SUPPLY CHAIN FSGB

POSTED

about 6 hours ago

DEADLINE

GLOBULIN, RHO (D) IMMUN

Solicitation # SPE2DP-26-T-5205

Solicitation SPE2DP-26-T-5205 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of two units of Globulin, Rho (D) Immune (NSN 6505-01-417-1250). The required product must meet USP standards, be provided as an adult dose of 300 mcg in a disposable 1ml syringe with safety for intramuscular injection, and must be stored at 2-8 degrees Celsius without freezing. The delivery is required within 20 days after the order, with the shipping destination specified as the USS Fitzgerald (DDG 62) in FPO AP 96665. The contract mandates strict adherence to hazardous materials regulations, requiring a current Material Safety Data Sheet (MSDS) and packaging that complies with 49 CFR, ICAO, and IMDG standards. All packaging and labeling must follow MIL-STD-129 and Medical Marking Standard No. 1. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and compliance with the Buy American and Balance of Payments Program. Quotations must be submitted via the DIBBS portal by September 29, 2026, and the government will perform both inspection and acceptance at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

CHARCOAL, ACTIVATED, SUS

Solicitation # SPE2DP-26-T-5206

Solicitation SPE2DP-26-T-5206, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotations for 10 bottles of activated charcoal suspension, NSN 6505-01-282-8880. Each bottle must contain 240 ml (50 grams) and maintain a shelf life of 36 months, with no more than five months elapsed from the date of manufacture to the delivery date. The product must be stored at 20 to 25 degrees Celsius and delivered FOB Destination to the USS Paul Hamilton DDG 60 within 20 days of award. The contractor must adhere to strict medical marking and packaging standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial and sealed to protect contents from damage, with palletization following RP001 requirements. Labels must include the NSN, manufacturer CAGE code, manufacture/expiration dates, and the contract or lot number. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for all invoicing and payment requests. The solicitation incorporates various FAR and DFARS clauses, including those regarding cybersecurity (DFARS 252.204-7012), hazardous material identification (FED-STD-313), and the Buy American Act. All quotes must be submitted via the DIBBS portal by September 29, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

DEXTROSE ORAL GEL

Solicitation # SPE2DP-26-T-5208

Solicitation SPE2DP-26-T-5208 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Dextrose Oral Gel. The requirement is for one package containing three 15-gram squeeze tubes with twist-off tips. The product is FDA regulated and must adhere to a strict shelf-life requirement of 18 months, with no more than 15 months having elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of order, with an original required delivery date of September 25, 2026. The shipment is destined for the USS South Dakota (SSN 790) in Groton, Connecticut, with FOB and inspection/acceptance points set at the destination. The contract mandates strict adherence to the DLA Master List of Technical and Quality Requirements, specifically RP001 for packaging, RA001 for general quality, and RS013 for shelf-life. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial per ASTM D3951 unless the material is deemed hazardous under FED-STD-313, in which case TQ requirement IP025 applies. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with the Buy American Act and NIST SP 800-171 for cybersecurity. Quotations must be submitted via the DIBBS system by September 29, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

6505--FY27 F18 Florebetapir

Solicitation # 36C24826Q1256

248-NETWORK Contract Office 8 (36C248)

POSTED

about 11 hours ago

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Supplier of Activated Charcoal SuspensionThis subcontract involves the supply of medical-grade activated charcoal suspension for prime contractors supporting the Department of Defense under the DLA Troop Support Medical Supply Chain Pharm FSA. The supplier is required to provide 10,000 bottles of product NSN 6505012828880, ensuring full compliance with the DLA Master List of Technical and Quality Requirements RA001. The contract mandates a strict delivery timeline of 20 days to the designated agency location in FPO 96667. Classified under NAICS code 423450, the opportunity was posted on September 23, 2026, with a response deadline of September 29, 2026.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 6 hours ago

DEADLINE

Temperature-Controlled Pharmaceutical DistributionThis subcontract for Temperature-Controlled Pharmaceutical Distribution involves the storage and transport of ophthalmic solutions to support prime contractors delivering medical supply contracts for DLA Troop Support. The service provider is responsible for managing cold chain logistics, ensuring that temperatures are strictly maintained between 2C and 25C using refrigerated vehicles, monitored warehouses, and data loggers. The operation is based in San Antonio, Texas, and requires strict adherence to Good Distribution Practice compliance and temperature validation certifications. The contractor is tasked with the secure delivery of these pharmaceutical products to designated DLA destinations under the oversight of the Department of Defense Medical Supply Chain Pharm FSA.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

about 6 hours ago

DEADLINE

Ophthalmic Dropperette Packaging SupplyThis subcontract for Ophthalmic Dropperette Packaging Supply supports prime contractors delivering medical supply contracts for the Department of Defense via the Medical Supply Chain Pharm FSA. The provider is responsible for producing sterile dropperettes and secondary pouch packaging using medical-grade plastics and specialized sealing equipment. Each delivery must be configured as 12 pouches containing two 0.1ML units. To ensure compliance with medical standards, the provider must maintain ISO 13485 certification and adhere to strict sterile packaging requirements. The performance of this contract is based in San Antonio, Texas, under NAICS code 326199. The solicitation was posted on September 23, 2026, with a response deadline of September 29, 2026.

All Other Plastics Product Manufacturing

POSTED

about 6 hours ago

DEADLINE

Pharmaceutical Packaging and Climate-Controlled DistributionThis subcontract for the Department of Defense under the Medical Supply Chain Pharm FSA involves the final packaging and specialized transport of pharmaceutical tablets. The contractor is responsible for bottling tablets into 30-count containers and applying labels in strict accordance with RP001 DLA Packaging Requirements. To ensure product stability and prevent degradation, the contractor must utilize humidity-controlled warehousing and climate-controlled transport vehicles. The scope of work concludes with the delivery of these packaged and labeled bottles to designated government destinations, with performance taking place at FPO 09591.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

about 6 hours ago

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS